Biden confirms Califf choice as FDA commissioner
President Joe Biden ended months of speculation by formally nominating Robert Califf as the new commissioner of the FDA, a [...]
Time to take patient engagement to the next level
The Covid pandemic has sparked people’s interest in science and medicine and empowered the public to make important health choices. [...]
Leveraging real-world data to meet payers’ needs
Payers are becoming savvier in accepting real-world data. Certara’s Lee Stern and Shawn Bates discuss the challenges and how pharma [...]
How biomarkers and bioanalytics are changing R&D
Biomarkers have been causing a paradigm shift in how HCPs treat patients for some time – now they are bringing [...]
Re-envisioning mental health treatment using clinical VR
Skip Rizzo, PhD, research director for medical virtual reality at the University of Southern California’s Institute for Creative Technologies (USC [...]
Time for change: PhRMA survey shows insurance creates barriers to healthcare in US
Health insurance is not enough to provide the necessary affordable access to care for the US’ most vulnerable, finds new [...]
Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China’s latest cost squeeze
Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China’s latest cost squeeze aliu Mon, 11/29/2021 [...]
Japan sees ‘drug lag’ as foreign pharmas pass up the market amid pricing pressure, industry group warns
Japan sees ‘drug lag’ as foreign pharmas pass up the market amid pricing pressure, industry group warns aliu Fri, 11/19/2021 [...]
Biden’s Medicare drug price negotiations will leave pharma mostly unscathed: CBO
Biden's Medicare drug price negotiations will leave pharma mostly unscathed: CBO fkansteiner Fri, 11/19/2021 - 09:52 Read the source article [...]
Call for Submissions: Flatiron Seeks Proposals for ResearchX RWD Presentation Series
Researchers who use Flatiron real-world data (RWD) in oncology are invited to submit proposals to present in Flatiron’s ResearchX series. [...]
New Depression Guidelines Released by NICE
The UK’s National Institute of Care and Excellence (NICE) has released their new guidance for depression diagnosis, treatment, and management. [...]
Interview with Ashok Roy, Chief Medical Officer of Caravan Medical, on Tuning in to the C-Suite Podcast
On Managed Healthcare Executive’s podcast, Tuning in to the C-Suite, Senior Editor Peter Wehrwein sits down to talk with Ashok [...]
FIECON orphan drug pricing white paper November 2021
Our white paper 'Is European market access the biggest potential prize in rare disease development?' explores the hypothesis that orphan [...]
With the Build Back Better Act, Congress Threatens Progress for Americans with Rare Diseases
Advocacy , Get Involved [With the Build Back Better Act, Congress Threatens Progress for Americans with Rare Diseases] Posted by [...]
Feds require health plans to report drug, coverage costs under new rule
Health insurers, employers and other group health plan sponsors must report prescription drug and health coverage costs for consumers under [...]
Democrats hit new crossroad in drug pricing talks
Quick Fix — The challenges of drug pricing legislation aren’t over yet , as Democrats wrangle over how far they [...]
Reconciling with Reconciliation Over Drug Pricing | Opinion
Reconciling with Reconciliation Over Drug Pricing | Opinion I am taking a break from writing about the health of our [...]
Drugmakers Gear Up for Price Restrictions in Biden’s Legislative Agenda – Wsj
The pharmaceutical industry is bracing for the most significant expansion of government regulation of drug prices in decades despite success [...]
Senate rules could undercut Democrats’ prescription drug plan
A critical part of Democrats’ plan to control prescription drug prices would apply not only to the government’s Medicare program [...]
TRxADE Health : Announces Launch of Preferred Drug Discount Card as Part of New Health Services Organization Offering
TrxadeHSO™ Program Provides Healthcare-Adjacent Services to Vast User Network in Partnership with Paramount Rx, Empowering Independent Pharmacies to Remain at [...]
High Drug Prices: How We Got Here and How We Achieve Affordability
The current state of the pharmacy system is challenged by rising list prices, the affordability of new brand and specialty [...]
Unsubstantiated drug price hikes cost $1.67B last year
Pharmaceutical companies continue to increase the prices of their most profitable drugs despite minimal year-over-year improvements, according to a new [...]
Hoboken-based health care consultancy acquired by GHO Capital
Global Healthcare Opportunities said Monday that it acquired Genesis Research , a Hoboken-based provider of tech-enabled real-world evidence and health [...]
Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence
Abstract Since the 2019 novel coronavirus disease (COVID-19) outbreak in 2019 and the pandemic continues for more than one year, [...]
Real World Evidence Solutions Market 2021: Industry Growth, Competitive Analysis, Future Prospects and Forecast 2028
Research article on the global ‘Real World Evidence Solutions’ market based on validated methodologies and hypotheses constructing a high-quality and [...]